FDA must establish safe approval pathway for biosimilar drugs
December 14, 2010
Biologic drugs are often referred to as ”miracle drugs“ for good reason…
Latest News
FDA must establish safe approval pathway for biosimilar drugs
December 14, 2010
Biologic drugs are often referred to as ”miracle drugs“ for good reason…
Proceed with caution on creating ‘biosimilar’ drugs
November 15, 2010
Americans elected a new Congress on Nov. 2, but the voting booth wasn’t the only place where critical issues were at stake that day.
Proceed with caution on creating ‘biosimilar’ drugs
November 15, 2010
Americans elected a new Congress on Nov. 2, but the voting booth wasn’t the only place where critical issues were at stake that day.
The new battle over prescription drugs
November 11, 2010
Away from the spotlight of election news coverage, a committee of the U.S. Food and Drug Administration (FDA) held a hearing in a Washington suburb on the future of biologic drugs…
Biologics: Are Unsafe Drugs an ‘Acceptable Risk?’ FDA Should Say ‘No!’
November 7, 2010
For cancer patients, what is the “acceptable risk” that a drug will pose safety risks or won’t work properly?
Understanding the challenges of next generation medicine
November 1, 2010
The English writer Aldous Huxley once said that humanity has “an absolute and infinite capacity for taking things for granted.”
Clinical Trials Key to Keeping New Drugs Safe
October 29, 2010
Patient safety is a core component of our medical system.
Clinical Trials Key to Keeping New Drugs Safe
October 29, 2010
Patient safety is a core component of our medical system.
